Pharma Groups Back Pfizer In 3rd Circ. Pay-For-Delay Case
Pharmaceutical groups on Monday asked the Third Circuit not to revive claims that Pfizer Inc. illegally paid Ranbaxy Laboratories Inc. to postpone its generic of cholesterol drug Lipitor, arguing that all...To view the full article, register now.
Already a subscriber? Click here to view full article